Original Research
Published on 08 Aug 2024
Multidimensional role of adapalene in regulating cell death in multiple myeloma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1415224
- 1,120 views
Type at least 3 characters
2,597 articles
Articles
Original Research
Published on 07 Aug 2024
Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1432520
- 966 views
Brief Research Report
Published on 07 Aug 2024
The first-in-class pro-apoptotic peptide PEP-010 is effective in monotherapy and in combination with paclitaxel on resistant ovarian adenocarcinoma cell models
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1444973
- 1,145 views
Original Research
Published on 07 Aug 2024
EMT-related gene classifications predict the prognosis, immune infiltration, and therapeutic response of osteosarcoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1419040
- 874 views
Original Research
Published on 07 Aug 2024
Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1369563
- 1,023 views
- 2 citations
Review
Published on 07 Aug 2024
Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1432603
- 1,019 views
Original Research
Published on 06 Aug 2024
Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1443045
- 2,140 views
- 2 citations
Review
Published on 05 Aug 2024
Anti-tumor effect and hepatotoxicity mechanisms of psoralen
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1442700
- 1,061 views
Review
Published on 05 Aug 2024
Chitosan-based biomaterial delivery strategies for hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446030
- 872 views
Original Research
Published on 05 Aug 2024
Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1391972
- 951 views
- 1 citation
Review
Published on 05 Aug 2024
Unveiling the multifaceted roles of microRNAs in extracellular vesicles derived from mesenchymal stem cells: implications in tumor progression and therapeutic interventions
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1438177
- 901 views
Correction
Published on 05 Aug 2024
Corrigendum: Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418274
- 537 views
Systematic Review
Published on 05 Aug 2024
Confirming the efficacy and safety of CDK4/6 inhibitors in the first-line treatment of HR+ advanced breast cancer: a systematic review and meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1369420
- 1,480 views
Review
Published on 02 Aug 2024
Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431958
- 883 views
Original Research
Published on 31 Jul 2024
Synergistic antitumor activity of baicalein combined with almonertinib in almonertinib-resistant non-small cell lung cancer cells through the reactive oxygen species-mediated PI3K/Akt pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1405521
- 1,133 views
Original Research
Published on 31 Jul 2024
MDM2 inhibitor APG-115 synergizes with ABT-199 to induce cell apoptosis in chronic lymphocytic leukemia
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1441383
- 955 views